Trial Profile
Effects of edaravone within 4.5h acute ischaemic stroke on frequency of symptomatic intracranial haemorrhage in patients receiving recombinant tissue-plasminogen activator (rt-PA)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs Edaravone (Primary) ; Alteplase
- Indications Stroke
- Focus Therapeutic Use
- Acronyms PROTECT4.5
- 14 Dec 2015 New trial record